Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 61-70 of 132 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
1996Effects of Continuous Calcitonin Treatment on Osteoclast-like Cell Development and Clacitonin Receptor Expression in Mouse Bone Marrow CulturesIkegame, M.; Rakopoulos, M.; Martin, T.; Moseley, J.; Findlay, D.
1997Bone BiologyNg, K.; Romas, E.; Donnan, L.; Findlay, D.
1998Casein kinase 2 phosphorylation of recombinant rat osteopontin enhances adhesion of osteoclasts but not osteoblastsKatayama, Y.; House, C.; Udagawa, N.; Kazama, J.; McFarland, R.; Martin, T.; Findlay, D.
2009Strontium ranelate treatment of human primary osteoblasts promotes an osteocyte-like phenotype while eliciting an osteoprotegerin responseAtkins, G.; Welldon, K.; Halbout, P.; Findlay, D.
2011Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivoZinonos, I.; Labrinidis, A.; Lee, M.; Liapis, V.; Hay, S.; Ponomarev, V.; Diamond, P.; Findlay, D.; Zannettino, A.; Evdokiou, A.
2013Calcium induces pro-anabolic effects on human primary osteoblasts associated with acquisition of mature osteocyte markersWelldon, K.; Findlay, D.; Evdokiou, A.; Ormsby, R.; Atkins, G.
2010Zoledronic acid protects against osteosarcoma-induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat modelLabrinidis, A.; Hay, S.; Liapis, V.; Findlay, D.; Evdokiou, A.
2011Relationship between serum RANKL and RANKL in boneFindlay, D.; Atkins, G.
2011Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanismAtkins, G.; Rowe, P.; Lim, H.; Welldon, K.; Ormsby, R.; Wijenayaka, A.; Zelenchuk, L.; Evdokiou, A.; Findlay, D.
2012Osteocyte regulation of bone mineral: a little give and takeAtkins, G.; Findlay, D.